Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s MOH-SFDA Merger: Analysts Weigh In

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China has reorganized the Ministry of Health and put the State FDA under its jurisdiction. The State Council's institutional restructuring scheme was officially approved March 15 at the first session of the 11 National People's Congress held in Beijing

You may also be interested in...



China Arrests Five SFDA Officials On Bribery Charges

SHANGHAI - Chinese authorities earlier this month arrested five officials from the State FDA and the National Institute for the Control of Pharmaceutical and Biological Products for taking bribes, according to reports by the government-run Xinhua News Agency

China Arrests Five SFDA Officials On Bribery Charges

SHANGHAI - Chinese authorities earlier this month arrested five officials from the State FDA and the National Institute for the Control of Pharmaceutical and Biological Products for taking bribes, according to reports by the government-run Xinhua News Agency

China Passes Food Safety Law Following Melamine Infant Formula Disasters

SHANGHAI - China's top legislature passed the long-awaited Food Safety Law in response to a national call for stricter food safety following the Sanlu dairy melamine incident, which led to the deaths of six infants last year (PharmAsia News, Jan. 5, 2009)

Related Content

UsernamePublicRestriction

Register

LL1132972

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel